Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  tegafur-uracil
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-18 of 18 for your search:
Start Over
Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: HGCSG-CAD, NCT00209742
A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 75
Sponsor: Other
Protocol IDs: JCOG-0205-MF, C000000193, NCT00190515
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 to 80
Sponsor: Other
Protocol IDs: CDR0000512573, TMDU-BRI-CC-05-01, NCT00392899
A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: MCSGO-CCTG-0501, NCT00385970
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 20 to 80
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDR0000593164, TMDU-TRICC0706, TRICC0706, NCT00660894
Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: COLOCROSS, NCT00905047
Phase II Study with UFT Plus Leucovorin Calcium for Metastatic Gastric Cancer (Summary Last Modified 09/98)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: EORTC-16964G
Fluorouracil-Uracil and Leucovorin in Treating Elderly Patients With Metastatic Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 75 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067511, E-1299, NCT00004860
A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor: Other
Protocol IDs: BMS-200604, UMCC 0110g, NCT00037089
Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: EMR200025-001, NCT00439517
Sorafenib Plus Tegafur/Uracil (UFUR®) for Hepatocellular Carcinoma (HCC)
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 950914, NCT00464919
UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: 940813, TTY-TU0510, NCT00519688
Gemcitabine-UFTE Chemotherapy in Refractory Colorectal Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CRC-SNU-2011-01, NCT01409005
Combination Chemotherapy In Treating Patients With Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067112, P30CA022453, WSU-D-1641, WSU-04-28-98-M02-FB, NCI-G99-1526, NCT00003925
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Closed
Age: 20 to 80
Sponsor: Other
Protocol IDs: CDR0000551714, TMDU-BRI-CC-05-02, BRI-CC-05-02, NCT00898846
Start Over